Author Question: Researchers who have assessed adult attachment styles have contacted research participants again, ... (Read 117 times)

bio_gurl

  • Hero Member
  • *****
  • Posts: 524
Researchers who have assessed adult attachment styles have contacted research participants again, months or years later. What percentage of participants have changed from one style to another?
 
  a. 10 to 20
  b. 25 to 30
  c. 40 to 50
  d. 50 to 70

Question 2

Social desirability bias is defined as
 
  A) the desire to be involved in social psychological research.
  B) a tendency of research participants to say what they believe is appropriate.
  C) the bias of a researcher to only report results that are consistent with his or her hypothesis.
  D) a sample that does not accurately reflect the composition of the population.



coyin

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: B

Answer to Question 2

Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library